Healthcare
Bruce Morimoto joins Cerecin as Vice President of Drug Development
uniQure N.V. announced the publication of 26-week interim data from the ongoing Phase IIb clinical trial of etranacogene dezaparvovec, an investigational gene therapy for hemophilia B, in the journal, Blood Advances.
Reston Hospital Center has recently renewed accreditation as a Center of Excellence in Minimally Invasive Gynecology by Surgical Review Corporation This accreditation distinguishes Reston Hospital Center from many other surgical facilities by providing the highest quality of care to patients as determined by an independent, external process of evaluation.
Scientific Posters Showcase Successful Treatment of Complex Wounds using NEOX® Cryopreserved Umbilical Cord Allograft to Accelerate Healing and Restore Function
Broadcast via Facebook Live from XXIV World Congress of Neurology, Dubai, UAE, Monday, Oct. 28, 7:15 am EDT
Just a few weeks after celebrating the treatment of its 3,000th pet, national pet cancer care provider PetCure Oncology presented data suggesting that advanced radiation therapy delivered within PetCure-developed treatment protocols is leading to better survival outcomes than other treatment options for at least nine specific tumor types.
Researchers at UCL Queen Square Institute of Neurology and the UCLH National Hospital for Neurology & Neurosurgery are set to test whether a drug can slow progression of the devastating neurodegenerative condition Multiple System Atrophy
Researchers found that an injectable hormone called tesamorelin decreases liver fat and prevented liver fibrosis in this patient population.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
GE Healthcare and Theragnostics have entered into a global commercial partnership for a new Prostate-Specific Membrane Antigen (PSMA) PET/CT imaging agent.
PRESS RELEASES